Merck & Co., Inc. logo

Merck & Co., Inc.

MRK
HealthcareNYSEUnited States
116.00USD+0.32 (+0.28%)

About Merck

Merck & Co., Inc. is a global healthcare company that operates through two main segments:

  • Pharmaceutical: This segment provides a broad range of human health pharmaceutical products in various areas, including oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. It also offers an extensive array of vaccine products aimed at pediatric, adolescent, and adult preventative care.

  • Animal Health: This segment focuses on the discovery, development, manufacture, and marketing of veterinary pharmaceuticals and vaccines. It also provides health management solutions and services, along with digitally connected identification, traceability, and monitoring products.

Merck serves a diverse clientele including drug wholesalers, retailers, hospitals, government agencies, managed healthcare providers, physicians, veterinarians, and animal producers.

The company maintains strategic partnerships with several industry leaders like AstraZeneca, Bayer, Eisai Co.,Ridgeback Biotherapeutics, and Gilead Sciences, particularly for the development and commercialization of long-acting HIV treatments.

Founded in 1891, Merck & Co., Inc. is headquartered in Kenilworth, New Jersey.

Merck's Business Strategy

​Merck & Co. operates a research-driven business model centered on the discovery, development, and commercialization of innovative medicines and vaccines. The company focuses on key therapeutic areas, including oncology, vaccines, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology. This strategic focus allows Merck to address…

Available on Finplify

Free account required

Sign up free

Our Take on Merck

Pros:

Blockbuster Oncology Franchise: Merck’s leading cancer immunotherapy drug (high-margin), Keytruda, is a cornerstone of its portfolio and one of the most successful oncology drugs globally. It is approved across a wide range of cancer types and continues to expand, driving strong and recurring…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
Employees
73,000
IPO Date
1978-01-13
ISIN
US58933Y1055
Website
merck.com

Key Metrics

Market Cap
286.80BUSD
P/E Ratio (TTM)
15.78
Net Profit Margin
28.08%
Debt / Asset Ratio
0.37
Dividend Yield (TTM)
2.87%
Volume
1.12M
Avg Volume
14.74M
Shares Outstanding
2.50B
Free Float
99.20%
β Beta
0.30
52W Range
73.3 - 125.1

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
4.8/5Excellent
Liquidity
3.6/5Good
Leverage
3.5/5Good
Cash Flow
4.5/5Excellent
Valuation
3.9/5Good

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Merck

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.